|
Product
|
NAP-2/CXCL7, Human
|
|
Cat#
|
101-27-168B
|
|
Sequence
|
AELRCMCIKT TSGIHPKNIQ SLEVIGKGTH CNQVEVIATL
KDGRKICLDP DAPRIKKIVQ KKLAGDESAD
|
|
Unit/Weight
|
1 mg
|
|
Unit Price
|
$2093.00
|
|
Description
|
Neutrophil Activating Peptide 2 (NAP-2) is proteolytically processed carboxyl-terminal fragments of platelet basic protein (PBP) which is found in the alpha-granules of human platelets. NAP-2 is a member of the CXC chemokines. Similar to other ELR domain containing CXC chemokines such as IL-8 and the GRO proteins, NAP-2 has been shown to bind CXCR-2 and to chemoattract and activate neutrophils. Although CTAP-III, ?TG and PBP represent amino-terminal extended variants of NAP-2 and possess the same CXC chemokine domains, these proteins do not exhibit NAP-2 activity. Recently, it has been shown that the additional amino-terminal residues of CTAP-III masks the critical ELR receptor binding domain that is exposed on NAP-2 and may account for lack of NAP-2 activity.
|
|
Molecular Weight
|
Approximately 7.6 kDa, a single non-glycosylated polypeptide chain containing 70 amino acids.
|
|
Purity
|
> 97 % by SDS-PAGE and HPLC analyses.
|
|
Storage
|
This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
|
|